These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 21126694

  • 1. Laboratory based investigations for diagnosing gastroesophageal reflux disease.
    Dolder M, Tutuian R.
    Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):787-98. PubMed ID: 21126694
    [Abstract] [Full Text] [Related]

  • 2. Reflux monitoring: pH-metry, Bilitec and oesophageal impedance measurements.
    Pohl D, Tutuian R.
    Best Pract Res Clin Gastroenterol; 2009 Dec; 23(3):299-311. PubMed ID: 19505660
    [Abstract] [Full Text] [Related]

  • 3. Review article: modern technology in the diagnosis of gastro-oesophageal reflux disease--Bilitec, intraluminal impedance and Bravo capsule pH monitoring.
    Hirano I.
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():12-24. PubMed ID: 16483266
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring.
    Kohata Y, Fujiwara Y, Machida H, Okazaki H, Yamagami H, Tanigawa T, Watanabe K, Watanabe T, Tominaga K, Arakawa T.
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():58-62. PubMed ID: 22486873
    [Abstract] [Full Text] [Related]

  • 6. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy.
    Becker V, Bajbouj M, Waller K, Schmid RM, Meining A.
    Aliment Pharmacol Ther; 2007 Nov 15; 26(10):1355-60. PubMed ID: 17900268
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of reflux frequency during prolonged multichannel intraluminal impedance and pH monitoring on and off acid suppression therapy.
    Blonski W, Vela MF, Castell DO.
    J Clin Gastroenterol; 2009 Oct 15; 43(9):816-20. PubMed ID: 19398927
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Multichannel intraluminal impedance and pH monitoring in gastroesophageal reflux disease.
    Vela MF.
    Expert Rev Gastroenterol Hepatol; 2008 Oct 15; 2(5):665-72. PubMed ID: 19072344
    [Abstract] [Full Text] [Related]

  • 11. Multichannel intraluminal impedance and pH-metry for investigation of symptomatic gastroesophageal reflux disease.
    Weigt J, Mönkemüller K, Peitz U, Malfertheiner P.
    Dig Dis; 2007 Oct 15; 25(3):179-82. PubMed ID: 17827936
    [Abstract] [Full Text] [Related]

  • 12. An algorithm for diagnosis and treatment of refractory GERD.
    Hershcovici T, Fass R.
    Best Pract Res Clin Gastroenterol; 2010 Dec 15; 24(6):923-36. PubMed ID: 21126704
    [Abstract] [Full Text] [Related]

  • 13. Gastroesophageal reflux monitoring: pH (catheter and capsule) and impedance.
    Hong SK, Vaezi MF.
    Gastrointest Endosc Clin N Am; 2009 Jan 15; 19(1):1-22, v. PubMed ID: 19232277
    [Abstract] [Full Text] [Related]

  • 14. The diagnosis of gastroesophageal reflux disease.
    Dughera L, Navino M, Cassolino P, Pellicano R.
    Minerva Gastroenterol Dietol; 2007 Jun 15; 53(2):143-52. PubMed ID: 17557042
    [Abstract] [Full Text] [Related]

  • 15. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo® wireless esophageal pH monitoring study.
    Schey R, Alla SP, Midani D, Parkman HP.
    Rev Gastroenterol Mex; 2017 Jun 15; 82(4):277-286. PubMed ID: 28385467
    [Abstract] [Full Text] [Related]

  • 16. Reflux monitoring: on or off therapy?
    Vaezi MF.
    Am J Gastroenterol; 2011 Feb 15; 106(2):183-5. PubMed ID: 21301447
    [Abstract] [Full Text] [Related]

  • 17. Biliary reflux and non-acid reflux are two distinct phenomena: a comparison between 24-hour multichannel intraesophageal impedance and bilirubin monitoring.
    Pace F, Sangaletti O, Pallotta S, Molteni P, Porro GB.
    Scand J Gastroenterol; 2007 Sep 15; 42(9):1031-9. PubMed ID: 17710667
    [Abstract] [Full Text] [Related]

  • 18. Update in the diagnosis of gastroesophageal reflux disease.
    Tutuian R.
    J Gastrointestin Liver Dis; 2006 Sep 15; 15(3):243-7. PubMed ID: 17013449
    [Abstract] [Full Text] [Related]

  • 19. [pH-impedancemetry: clinical implications].
    Bertolini D, Roman S, Dumonceau JM.
    Rev Med Suisse; 2008 Sep 03; 4(169):1873-4, 1876-8. PubMed ID: 18831408
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.